Drug
QPX7831 clinical trials
Also written QPX7831.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2021
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
3 studies that test it; most in 2024 (2)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2024 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses QPX7831 is read from its arms, and is right about nine times in ten.
Testing it · 3
- P1, DDI & MAD PK and Safety Study of Xeruborbactam Oral Prodrug in Combo With Ceftibuten in Healthy ParticipantsCompletedPhase 1Qpex Biopharma, Inc.NCT06079775Written as Xeruborbactam Oral Prodrug
- PK & Safety Study of Xeruborbactam Oral Prodrug Combined With Ceftibuten in Participants With Renal ImpairmentCompletedPhase 1Qpex Biopharma, Inc.NCT06157242Written as Xeruborbactam Oral Prodrug
- Phase 1 Oral QPX7831 SAD and MAD in Healthy AdultsCompletedPhase 1Qpex Biopharma, Inc.NCT04578873Written as QPX7831